Indirect Response Mechanism
Indirect Response Mechanism - Related Videos
01:18
Indirect-Acting Cholinergic Agonists: Mechanism of Action
0 Views •
2023
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme. Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:29
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
0 Views •
2026
Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
14:22
ELISA Assays: Indirect, Sandwich, and Competitive
0 Views •
2023
Source: Whitney Swanson1,2, Frances V. Sjaastad2,3, and Thomas S. Griffith1,2,3,4 1 Department of Urology, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Enzyme-linked immunosorbent assay (ELISA) is frequently used to measure the presence...
08:32
Indirect Fabrication of Lattice Metals with Thin Sections Using Centrifugal Casting
0 Views •
Cited by 8 •
2016
An indirect additive manufacturing method combining a 3D printing of polymers with a centrifugal casting is outlined for manufacturing 3D octet truss metals (Al and Cu alloys) having a unit cell length of 5 mm with a wall thickness of 0.5 mm.
01:13
Cell-matrix's Response to Mechanical Forces
0 Views •
2023
In animal cells, the extracellular matrix allows cells within tissues to withstand external stresses and transmits signals from the outside of the cell to the inside. The extracellular matrix is extensive, and its composition varies between different types of tissues. For example, the reticular fibers and ground substance make up the ECM in loose connective tissue, while collagen and bone minerals make up the ECM of bone tissue. Anchoring junctions mechanically attach a cell to the...
FAQs
The measured response depends on how an intervention changes the mediator’s production or loss. Stimulating production can increase mediator levels, whereas inhibiting production can reduce them; changing loss produces the opposite directional effect. Because these processes determine mediator turnover, their balance controls both the magnitude and timing of the observed clinical response.
Mediator turnover separates the intervention’s immediate action from the later clinical measurement. The response may develop gradually as the mediator accumulates or is depleted, then remain altered while the mediator returns toward its prior state. Consequently, the measured effect can persist after drug concentrations decline, depending on the mediator’s turnover behavior.
Hysteresis occurs when the measured response does not follow the concentration profile at the same time point. During increasing and decreasing exposure, a given drug concentration may correspond to different response levels because the intermediate mediator changes over time. Recognizing this pattern helps distinguish delayed response behavior from an exposure-response relationship that tracks concentrations immediately.
Characterization requires time-related observations of drug exposure and the response mediator or clinical outcome. Comparing concentration profiles with biomarker, cell-population, or physiological-signal changes reveals delays, accumulation, and recovery. These observations allow investigators to relate intervention exposure to mediator turnover and assess why the measured response does not change simultaneously with plasma concentration.
Indirect response models connect exposure with the delayed development and resolution of a clinical effect. Investigators can use that relationship to evaluate candidate doses, anticipate when responses will emerge, and plan treatment intervals that account for mediator turnover. This supports schedules that reflect the time course of benefit or recovery rather than plasma concentrations alone.
Biomarkers can represent the intermediate process linking an intervention with a later clinical outcome. Tracking their changes over time helps identify whether the response is accumulating, delayed, or recovering after exposure changes. This information improves exposure-response interpretation and can clarify clinical findings when plasma concentration and observed effect appear temporally mismatched.